Clinical trial
Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow
NCT00447928 · Cure Therapeutics, Industry · Unknown status
Key facts
| NCT number | NCT00447928 |
|---|---|
| Title | Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Phase II Dose-Ranging Study of the OrthoDerm Transdermal Nitroglycerin Patch for Patients With Chronic Lateral Epicondylitis |
| Lead sponsor | Cure Therapeutics, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tendonitis |
| Intervention type | Drug |
| Interventions | OrthoDerm transdermal nitroglycerin patch |
| Enrollment | 164 |
| Start date | Apr 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Mar 15, 2007 |
| Last update posted | Mar 15, 2007 |
| Countries | Poland |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: